Информация по русски - English Information - Suche - Sitemap - Impressum   Home  
Illustriertes Logo Pulmonale Hypertonie e.V.
 

English Information 2

- Clinical picture
- Diagnosis
- Therapy


Clinical picture :
Severe pulmonary hypertension (PH) is a life-threatening disease, characterised by sustained elevation of pulmonary artery pressure and plexogeneic arteriopathy of the small pulmonary vessels due to different diseases. Some of these diseases are classified as pulmonary arterial hypertension (PAH) which is either idiopathic (IPAH, previously called as primary pulmonary hypertension, PPH) or related to the use of anorexigen drugs, portal hypertension, systemic connective disease, congenital heart disease, and HIV infection.
PH can also occur with chronic thromboembolic lung disease, diseases with hypoxemia or rare diseases. PH due to left heart failure or left heart valve disease is classified as pulmonary venous disease (PVH).

Who is affected by IPAH?
The disease can occur at any age, but most commonly in the third decade of life in woman and the fourth decade in men. Women are affected about twice as often as men.

Course:
Mostly progressive course, rarely spontaneous remission. The most frequent cause of death is chronic right ventricular failure.

Symptoms:
shortness of breath
chest pain
collapse
leg oedema
blue lips

Development of the symptoms:
Due to the constricted pulmonary vessels a very high pressure is needed for a sufficient blood flow. The right ventricle can only build up a limited pressure. The cardiac output is reduced and consequently the blood flow and oxygen supply of the organs.

Diagnosis:
Right heart catheterization with selective pulmonary vasodilator testing is indicated to confirm suspected PAH.
Echocardiography is the best non-invasive test for screening and follow-up of PAH by providing assessment of the right ventricular function, cardiac output and systolic pulmonary artery pressure.
Chest X-ray to exclude lung diseases and progression control of heart size.
Lung function tests to exclude lung disorders.
Blood gas analysis to check the indication for oxygen therapy.
Electrocardiography commonly reveals right axis deviation and prominent P-waves.
   
Therapy:
Several medical treatments are now available for severe pulmonary hypertension.
   
Cause of the disease
Special immunological features can often be identified, but their overall significance is still unclear.
Appetite suppressants increase the risk of PPH ten-fold.
   
Problems with the research in Germany
PH is a rare disease. There is little information about the frequency and prognosis of the disease in Germany.
At Heidelberg University the identification of genetical causes and possible early forms of the disease are currently investigated.
At Heidelberg, a family screening has been done for the first time. The Universities of Heidelberg and Gießen initiated a European Multicentric Study for the early diagnosis of PAH. The study is supported by the Commission of the EU.
   
 
Werden Sie Mitglied
Spenden Sie jetzt